Artivion (AORT) Income from Continuing Operations (2010 - 2026)
Artivion's (AORT) quarterly Income from Continuing Operations came in at 1417000.0 in Q1 2026, up 380.59% YoY from 294843.43 in Q1 2025, and down 41.59% on a QoQ basis from 2426000.0 in Q4 2025.
Artivion (AORT) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Artivion (AORT) has 17 years of Income from Continuing Operations data on file, last reported at 1417000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 380.59% year-over-year to 1417000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11690000.0 (up 154.63% YoY) and the FY2025 annual result came in at 9768000.0, up 173.12% from the prior year.
- Income from Continuing Operations fell to 1417000.0 in Q1 2026, from 2426000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 7533000.0 in Q1 2024 to a low of 16483000.0 in Q4 2024.
- A 5-year average of 3062117.65 and a median of 2288000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations tumbled 314.67% — and 2025, when it soared 384.18%.
- Tracing AORT's Income from Continuing Operations over 5 years: stood at 2169000.0 in 2022, then plunged by 283.26% to 3975000.0 in 2023, then plunged by 314.67% to 16483000.0 in 2024, then surged by 114.72% to 2426000.0 in 2025, then plunged by 41.59% to 1417000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 1417000.0 (Q1 2026), 2426000.0 (Q4 2025), and 6502000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Artivion | 1.38 Bn | 1.31 Bn | 80.52 Mn | -13.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.51 Mn |
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | -505,000.00 |
| Dec 31, 2024 | -16.48 Mn |
| Sep 30, 2024 | -2.29 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | -3.98 Mn |
| Sep 30, 2023 | -9.80 Mn |
| Jun 30, 2023 | -3.38 Mn |
| Mar 31, 2023 | -13.53 Mn |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | -13.71 Mn |
| Jun 30, 2022 | -4.26 Mn |
| Mar 31, 2022 | -3.39 Mn |
| Dec 31, 2021 | -20.10 Mn |
| Sep 30, 2021 | 10.58 Mn |